THE EFFICACY OF N-ACETYL CYSTEINE AS AN ADJUVANT THERAPY IN BEHCET'S DISEASE, A RANDOMIZED DOUBLE BLIND CONTROL STUDY

MLA

Farhad Shahram, et al. The Efficacy of N-Acetyl Cysteine as an Adjuvant Therapy in Behcet’s Disease, a Randomized Double Blind Control Study. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..697f7ac75fd615b101af83cc492d5293&authtype=sso&custid=ns315887. Accessed 9 Mar. 2025.

APA

Farhad Shahram, Moobedi, Z., Akhlaghi, M., Ghaffari, R., Hashemian, F., Dahaghin, S., Aryaeian, N., Azar, Z. J., Naderi, N., & Davatchi, F. (n.d.). The Efficacy of N-Acetyl Cysteine as an Adjuvant Therapy in Behcet’s Disease, a Randomized Double Blind Control Study.

Chicago

Farhad Shahram, Z. Moobedi, M. Akhlaghi, R. Ghaffari, F. Hashemian, S. Dahaghin, N. Aryaeian, Z. Jafari Azar, N. Naderi, and F. Davatchi. 2025. “The Efficacy of N-Acetyl Cysteine as an Adjuvant Therapy in Behcet’s Disease, a Randomized Double Blind Control Study.” Accessed March 9. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..697f7ac75fd615b101af83cc492d5293&authtype=sso&custid=ns315887.